CAMP4 Therapeutics CorporationCAMPNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-74.68%
↓ 1884% below average
Average (39q)
-3.76%
Historical baseline
Range
High:74.48%
Low:-100.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -74.68% |
| Q2 2025 | 74.48% |
| Q1 2025 | 31.60% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | -98.71% |
| Q2 2023 | -2.44% |
| Q1 2023 | 4.22% |
| Q4 2022 | -8.27% |
| Q3 2022 | 13.12% |
| Q2 2022 | -8.56% |
| Q1 2022 | 0.10% |
| Q4 2021 | -16.03% |
| Q3 2021 | 2.84% |
| Q2 2021 | -6.22% |
| Q1 2021 | -1.16% |
| Q4 2020 | 13.62% |
| Q3 2020 | -0.78% |
| Q2 2020 | -6.85% |
| Q1 2020 | -9.61% |
| Q4 2019 | -2.09% |
| Q3 2019 | 6.38% |
| Q2 2019 | 5.80% |
| Q1 2019 | -8.00% |
| Q4 2018 | -8.64% |
| Q3 2018 | 4.54% |
| Q2 2018 | -0.86% |
| Q1 2018 | 0.62% |
| Q4 2017 | 3.66% |
| Q3 2017 | -1.62% |
| Q2 2017 | 4.63% |
| Q1 2017 | 1.91% |
| Q4 2016 | -6.64% |
| Q3 2016 | 7.98% |
| Q2 2016 | 26.41% |
| Q1 2016 | 3.70% |
| Q4 2015 | 5.02% |